Skip to main content

ADVERTISEMENT

Multikinase inhibitors

Research in Review
03/17/2017
JCP Editors
Overall response rate (ORR) is low for patients with non-small cell lung cancer (NSCLC) with RET rearrangements after targeted therapy, according to research published in the Journal of Clinical Oncology (March 13,...
Overall response rate (ORR) is low for patients with non-small cell lung cancer (NSCLC) with RET rearrangements after targeted therapy, according to research published in the Journal of Clinical Oncology (March 13,...
...
03/17/2017
Journal of Clinical Pathways